Plain-English translation of NCT07592923 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing micropulse transscleral cyclophotocoagulation (MP-CPC), a laser procedure that lowers eye pressure in people with glaucoma. Researchers want to understand why the treatment works better for some patients than others by measuring changes in the eye's choroid—a layer of tissue that supplies blood to the eye—before and after the procedure.
Glaucoma causes permanent vision loss, and lowering eye pressure is the only way to slow it down. While this laser treatment is safe and effective, doctors don't yet know how to predict which patients will benefit most from it or how long the pressure reduction will last. This study aims to find those answers by identifying specific eye measurements that predict treatment success.
You likely qualify if…
You likely don't qualify if…
You would receive the laser procedure as planned with your eye doctor. Before the procedure, immediately after (within 3–7 days), and again at 1 month, you'll have imaging scans of your eye and measurements of your eye pressure. The entire study takes about 1 month, with three clinical visits. There are no additional medications or lifestyle changes required.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Kazakhstan